Exchange: NASDAQ·Updated 02:05 PM EDT
TMDX logo

TMDXTransmedics Group Inc

$70.55
$0.58
(0.81%)
Today
EarningsAug 4
Mkt Cap$2.46B
Vol300,593.00
News
all
press releases
TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026
TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026 TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026 PR Newswire ANDOVER, Mass., July 21, 2026 ANDOVER, Mass., July 21, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX...
PR Newswire
More News
TransMedics Completes PAD Aviation Investment to Expand in Europe
TMDX's PAD Aviation investment expands its OCS model into Europe, aiming to boost organ logistics, utilization and adoption.
Zacks
Where Will TransMedics Group Stock Be in 10 Years?
Where Will TransMedics Group Stock Be in 10 Years...
Yahoo! Finance: News
TMDX Stock Rallies As Analyst Sees 77% Upside — Here’s Why
TD Cowen maintained its ‘Buy’ rating on TransMedics with a $120 price target.
Stocktwits
Reasons to Retain TransMedics Stock in Your Portfolio for Now
TMDX is advancing its OCS platform and transplant ecosystem, but margin pressure from expansion investments remains a key concern.
Zacks
TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound?
TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
This Healthcare Infrastructure Stock Is Risky, But the Upside Looks Huge
TransMedics (NASDAQ: TMDX) has been hit hard as investors question margins, spending, and execution. But beneath the sell-off, the company's Organ Care System, aviation network, and National OCS Program could be building a deeper transplant infrastructure moat than the market rea...
Nasdaq News: Markets
Reasons to Retain TransMedics Stock in Your Portfolio for Now
TMDX is advancing its OCS platform and transplant ecosystem, but margin pressure from expansion investments remains a key concern.
Zacks
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire ANDOVER, Mass., May 21, 2026 ANDOVER, Mass., May 21, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a...
PR Newswire
TransMedics to Present at the William Blair 46th Annual Growth Stock Conference
TransMedics to Present at the William Blair 46th Annual Growth Stock Conference TransMedics to Present at the William Blair 46th Annual Growth Stock Conference PR Newswire ANDOVER, Mass., May 19...
PR Newswire
<
1
2
...
>

Advertisement|Remove ads.